DAPAWORT 10 MG contains Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor that works by increasing glucose excretion in the urine, thereby lowering blood sugar levels in patients with type 2 diabetes mellitus. This medication is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.